As people prepare for the festive season and temperatures start to drop, there's a simple 'trick' that can help support your respiratory health and immune system ...
Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).